Skip to content

Testing Latest Version of NidekRS3000Adv

Testing Latest Version of NidekRS3000Adv

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03318705
Enrollment
100
Registered
2017-10-24
Start date
2018-02-01
Completion date
2018-03-28
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Interventions

DEVICERS3000Adv

Nidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Sponsors

Doheny Image Reading Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy participants * 18 years old or older

Exclusion criteria

* Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging * subjects who are unable to maintain retinal fixation on a specified target * subjects unable to achieve sufficient pupil dilation and alignment stability for imaging to take place * subjects with media opacity which preclude high quality imaging will be excluded. * vulnerable subjects * subjects under 18 * pregnant subjects * economically and educationally disadvantaged subjects * decision impaired subjects * homeless subjects

Design outcomes

Primary

MeasureTime frameDescription
Ocular vascularization1 yearNidek RS3000Adv device to be used to take images which will allow measurement of vascularization in participants

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026